

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.92735692 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.92735692 |
| 3 | protein retention in ER lumen (GO:0006621) | 5.73604090 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.73471072 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.54554637 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.05376338 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.88096752 |
| 8 | protein maturation by protein folding (GO:0022417) | 4.56848448 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.56257310 |
| 10 | proline biosynthetic process (GO:0006561) | 4.47697399 |
| 11 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.46564102 |
| 12 | positive regulation of synapse maturation (GO:0090129) | 4.35826469 |
| 13 | glutamate secretion (GO:0014047) | 4.30107234 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 4.29744331 |
| 15 | layer formation in cerebral cortex (GO:0021819) | 4.23898643 |
| 16 | regulation of synapse structural plasticity (GO:0051823) | 4.01102222 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.00674121 |
| 18 | regulation of early endosome to late endosome transport (GO:2000641) | 3.90456220 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.86423080 |
| 20 | sodium ion export (GO:0071436) | 3.82860424 |
| 21 | NADH metabolic process (GO:0006734) | 3.81394398 |
| 22 | negative regulation of microtubule polymerization (GO:0031115) | 3.79407476 |
| 23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.77451971 |
| 24 | vocalization behavior (GO:0071625) | 3.71529753 |
| 25 | cell migration in hindbrain (GO:0021535) | 3.67020798 |
| 26 | gluconeogenesis (GO:0006094) | 3.67011788 |
| 27 | cell communication by electrical coupling (GO:0010644) | 3.61894941 |
| 28 | neuromuscular process controlling posture (GO:0050884) | 3.54826606 |
| 29 | L-serine metabolic process (GO:0006563) | 3.54798028 |
| 30 | monosaccharide biosynthetic process (GO:0046364) | 3.51592034 |
| 31 | pentose-phosphate shunt (GO:0006098) | 3.51403995 |
| 32 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.49093384 |
| 33 | neuromuscular process controlling balance (GO:0050885) | 3.47944595 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.47636888 |
| 35 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.47062589 |
| 36 | mitotic nuclear envelope reassembly (GO:0007084) | 3.46110914 |
| 37 | nuclear envelope reassembly (GO:0031468) | 3.46110914 |
| 38 | cerebellar Purkinje cell layer development (GO:0021680) | 3.46041113 |
| 39 | hexose biosynthetic process (GO:0019319) | 3.45832489 |
| 40 | neurotransmitter secretion (GO:0007269) | 3.44302477 |
| 41 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.41072958 |
| 42 | exploration behavior (GO:0035640) | 3.39956750 |
| 43 | regulation of synaptic vesicle transport (GO:1902803) | 3.38628609 |
| 44 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.38526638 |
| 45 | glycolytic process (GO:0006096) | 3.36448445 |
| 46 | NADPH regeneration (GO:0006740) | 3.35363546 |
| 47 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.35307804 |
| 48 | neuronal action potential propagation (GO:0019227) | 3.35052117 |
| 49 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.32854961 |
| 50 | negative regulation of cell size (GO:0045792) | 3.29460276 |
| 51 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.28662814 |
| 52 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.27410681 |
| 53 | dendritic spine morphogenesis (GO:0060997) | 3.26084350 |
| 54 | proline metabolic process (GO:0006560) | 3.25434564 |
| 55 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.21298664 |
| 56 | cellular potassium ion homeostasis (GO:0030007) | 3.18545730 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.18444644 |
| 58 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.15929906 |
| 59 | GDP-mannose metabolic process (GO:0019673) | 3.15833362 |
| 60 | establishment of viral latency (GO:0019043) | 3.14213766 |
| 61 | cell-cell junction maintenance (GO:0045217) | 3.10139189 |
| 62 | protein localization to synapse (GO:0035418) | 3.08095838 |
| 63 | regulation of translational termination (GO:0006449) | 3.05371381 |
| 64 | establishment of integrated proviral latency (GO:0075713) | 3.03452379 |
| 65 | glucose catabolic process (GO:0006007) | 3.03436081 |
| 66 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.99831008 |
| 67 | barbed-end actin filament capping (GO:0051016) | 2.98461685 |
| 68 | oxaloacetate metabolic process (GO:0006107) | 2.97805175 |
| 69 | glucose 6-phosphate metabolic process (GO:0051156) | 2.96283512 |
| 70 | 4-hydroxyproline metabolic process (GO:0019471) | 2.95591524 |
| 71 | proline transport (GO:0015824) | 2.95293669 |
| 72 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.94007734 |
| 73 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.91851420 |
| 74 | tricarboxylic acid cycle (GO:0006099) | 2.90459621 |
| 75 | tricarboxylic acid metabolic process (GO:0072350) | 2.85157092 |
| 76 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.83314966 |
| 77 | mitochondrion transport along microtubule (GO:0047497) | 2.82284427 |
| 78 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.82284427 |
| 79 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.80793759 |
| 80 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.79321028 |
| 81 | adenine nucleotide transport (GO:0051503) | 2.77264832 |
| 82 | regulation of translational fidelity (GO:0006450) | 2.75658237 |
| 83 | protein complex localization (GO:0031503) | 2.75605636 |
| 84 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.75163086 |
| 85 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.74610129 |
| 86 | positive regulation of sodium ion transport (GO:0010765) | 2.72718971 |
| 87 | positive regulation of membrane potential (GO:0045838) | 2.71544758 |
| 88 | cell junction maintenance (GO:0034331) | 2.69321875 |
| 89 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.69023770 |
| 90 | dendritic spine organization (GO:0097061) | 2.68882157 |
| 91 | amino acid import (GO:0043090) | 2.68616177 |
| 92 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.68082986 |
| 93 | long-term memory (GO:0007616) | 2.67728598 |
| 94 | regulation of synaptic plasticity (GO:0048167) | 2.67502290 |
| 95 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.67429629 |
| 96 | regulation of synapse maturation (GO:0090128) | 2.67428919 |
| 97 | positive regulation of nuclease activity (GO:0032075) | 2.66671497 |
| 98 | vesicle coating (GO:0006901) | 2.65705075 |
| 99 | protein localization to endosome (GO:0036010) | 2.63313508 |
| 100 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.62286917 |
| 101 | histone arginine methylation (GO:0034969) | 2.61899933 |
| 102 | neurotransmitter transport (GO:0006836) | 2.61317229 |
| 103 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.61012824 |
| 104 | neuromuscular process (GO:0050905) | 2.59119902 |
| 105 | establishment of mitochondrion localization (GO:0051654) | 2.57333133 |
| 106 | cell communication involved in cardiac conduction (GO:0086065) | 2.56962745 |
| 107 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.56838682 |
| 108 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.56715698 |
| 109 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.56067731 |
| 110 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.55819040 |
| 111 | synaptic transmission, glutamatergic (GO:0035249) | 2.53979857 |
| 112 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.53209935 |
| 113 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.53209935 |
| 114 | maternal placenta development (GO:0001893) | 2.51884415 |
| 115 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.51598257 |
| 116 | regulation of mitotic spindle organization (GO:0060236) | 2.51409494 |
| 117 | protein insertion into membrane (GO:0051205) | 2.51251337 |
| 118 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.50200048 |
| 119 | prepulse inhibition (GO:0060134) | 2.49955540 |
| 120 | behavioral defense response (GO:0002209) | 2.49592288 |
| 121 | behavioral fear response (GO:0001662) | 2.49592288 |
| 122 | regulation of neurotransmitter levels (GO:0001505) | 2.49172552 |
| 123 | response to parathyroid hormone (GO:0071107) | 2.49025438 |
| 124 | organelle transport along microtubule (GO:0072384) | 2.48034129 |
| 125 | cellular protein complex localization (GO:0034629) | 2.47389614 |
| 126 | gamma-aminobutyric acid transport (GO:0015812) | 2.46083440 |
| 127 | positive regulation of dendritic spine development (GO:0060999) | 2.46046444 |
| 128 | glycine transport (GO:0015816) | 2.44499160 |
| 129 | peptidyl-arginine N-methylation (GO:0035246) | 2.44418922 |
| 130 | peptidyl-arginine methylation (GO:0018216) | 2.44418922 |
| 131 | dopamine receptor signaling pathway (GO:0007212) | 2.43410958 |
| 132 | lung-associated mesenchyme development (GO:0060484) | 2.42234083 |
| 133 | pyruvate metabolic process (GO:0006090) | 2.41562674 |
| 134 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.40735257 |
| 135 | cerebellar granule cell differentiation (GO:0021707) | 2.40695800 |
| 136 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.40418284 |
| 137 | de novo posttranslational protein folding (GO:0051084) | 2.40353545 |
| 138 | cellular sodium ion homeostasis (GO:0006883) | 2.39820996 |
| 139 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.39261072 |
| 140 | synaptic vesicle endocytosis (GO:0048488) | 2.38865980 |
| 141 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.38091256 |
| 142 | response to pheromone (GO:0019236) | 2.38085463 |
| 143 | activation of Rac GTPase activity (GO:0032863) | 2.37813182 |
| 144 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.37811445 |
| 145 | adherens junction assembly (GO:0034333) | 2.37659282 |
| 146 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.37362267 |
| 147 | chemosensory behavior (GO:0007635) | 2.36753136 |
| 148 | plasma membrane repair (GO:0001778) | 2.36188112 |
| 149 | neuron-neuron synaptic transmission (GO:0007270) | 2.35399772 |
| 150 | neuron cell-cell adhesion (GO:0007158) | 2.35251441 |
| 151 | C4-dicarboxylate transport (GO:0015740) | 2.35188565 |
| 152 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.35180059 |
| 153 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.34737170 |
| 154 | stress fiber assembly (GO:0043149) | 2.34633472 |
| 155 | peptidyl-proline hydroxylation (GO:0019511) | 2.34309714 |
| 156 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.34178985 |
| 157 | purine nucleotide transport (GO:0015865) | 2.33998545 |
| 158 | neuronal ion channel clustering (GO:0045161) | 2.33735475 |
| 159 | de novo protein folding (GO:0006458) | 2.33358575 |
| 160 | anterior/posterior axis specification, embryo (GO:0008595) | 2.33296199 |
| 161 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.33019420 |
| 162 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.32986381 |
| 163 | protein targeting to plasma membrane (GO:0072661) | 2.32640090 |
| 164 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.31892978 |
| 165 | innervation (GO:0060384) | 2.31760204 |
| 166 | negative regulation of catenin import into nucleus (GO:0035414) | 2.31266026 |
| 167 | dendrite morphogenesis (GO:0048813) | 2.31168421 |
| 168 | mitochondrial fusion (GO:0008053) | 2.31110484 |
| 169 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.30122598 |
| 170 | regulation of nuclease activity (GO:0032069) | 2.27310738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.91733891 |
| 2 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.79779824 |
| 3 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.73980450 |
| 4 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.67099272 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.54026921 |
| 6 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.46267647 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.41882805 |
| 8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.34605745 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.32650644 |
| 10 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.29727602 |
| 11 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.25618067 |
| 12 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 2.24487371 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.20420025 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.12483787 |
| 15 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.08523574 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.04797627 |
| 17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.97471303 |
| 18 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96846787 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.96186717 |
| 20 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.95238455 |
| 21 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.95025340 |
| 22 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.94204020 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.89529335 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.88594348 |
| 25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.82442806 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.81810984 |
| 27 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.81179564 |
| 28 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.80494032 |
| 29 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.75921562 |
| 30 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.75290009 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.72648931 |
| 32 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72445703 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71755762 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71658728 |
| 35 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.68912779 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.67676684 |
| 37 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.62519861 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61706219 |
| 39 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.60593781 |
| 40 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60318702 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59663535 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59165595 |
| 43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.57535999 |
| 44 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.56993704 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.56993704 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55449910 |
| 47 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.55043412 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.53677650 |
| 49 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52763478 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49842424 |
| 51 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.49802920 |
| 52 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.48464699 |
| 53 | P68_20966046_ChIP-Seq_HELA_Human | 1.48036993 |
| 54 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.47848586 |
| 55 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.47673018 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.46322980 |
| 57 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.46201337 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44169826 |
| 59 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.42781121 |
| 60 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.40851826 |
| 61 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.40821416 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.40007833 |
| 63 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.37899631 |
| 64 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.37135390 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37014007 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36558511 |
| 67 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.36488691 |
| 68 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36118117 |
| 69 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.36079035 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35458544 |
| 71 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35321388 |
| 72 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.34642351 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34575527 |
| 74 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.34296569 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33707943 |
| 76 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.33419972 |
| 77 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33365287 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.32564239 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30491913 |
| 80 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30291241 |
| 81 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.30095739 |
| 82 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.29879354 |
| 83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.29370902 |
| 84 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29160693 |
| 85 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.29038644 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.29009685 |
| 87 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28849810 |
| 88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.28501698 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27861566 |
| 90 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.27859267 |
| 91 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26995015 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26829086 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25953221 |
| 94 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.24287279 |
| 95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24211462 |
| 96 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23859399 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.23858610 |
| 98 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.23714993 |
| 99 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.23277495 |
| 100 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.23277495 |
| 101 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.23277495 |
| 102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.23115647 |
| 103 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.23064160 |
| 104 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.22841968 |
| 105 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.22342841 |
| 106 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.22039815 |
| 107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22034983 |
| 108 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21862529 |
| 109 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.21569791 |
| 110 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.20177462 |
| 111 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.19584412 |
| 112 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18606110 |
| 113 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18169454 |
| 114 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17986015 |
| 115 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.16908006 |
| 116 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.15881813 |
| 117 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15032969 |
| 118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14839110 |
| 119 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14663033 |
| 120 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13981285 |
| 121 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.12722530 |
| 122 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.12174885 |
| 123 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11516725 |
| 124 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.11382591 |
| 125 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.11334419 |
| 126 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11294190 |
| 127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10153177 |
| 128 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09994198 |
| 129 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.09842722 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09596648 |
| 131 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.09442243 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09426390 |
| 133 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09281156 |
| 134 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.08754983 |
| 135 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07845475 |
| 136 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07467417 |
| 137 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07114296 |
| 138 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.06999444 |
| 139 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06528756 |
| 140 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06282074 |
| 141 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.06189552 |
| 142 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06096436 |
| 143 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.05964327 |
| 144 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05700537 |
| 145 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05320760 |
| 146 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04706713 |
| 147 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.04479543 |
| 148 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.04307417 |
| 149 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.04248572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.56601408 |
| 2 | MP0004270_analgesia | 3.15511988 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.11439785 |
| 4 | MP0004858_abnormal_nervous_system | 2.93443260 |
| 5 | MP0008260_abnormal_autophagy | 2.76799826 |
| 6 | MP0003329_amyloid_beta_deposits | 2.65024449 |
| 7 | MP0003880_abnormal_central_pattern | 2.58881889 |
| 8 | MP0002653_abnormal_ependyma_morphology | 2.51630392 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.43995611 |
| 10 | MP0005451_abnormal_body_composition | 2.29949033 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.18569544 |
| 12 | MP0002064_seizures | 2.15914129 |
| 13 | MP0002909_abnormal_adrenal_gland | 2.09900720 |
| 14 | MP0003283_abnormal_digestive_organ | 2.07901923 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.06670130 |
| 16 | MP0009745_abnormal_behavioral_response | 2.06204971 |
| 17 | MP0002822_catalepsy | 1.97752924 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.94489289 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 1.93758545 |
| 20 | MP0009046_muscle_twitch | 1.87992024 |
| 21 | MP0000678_abnormal_parathyroid_gland | 1.87963512 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 1.86841012 |
| 23 | MP0002249_abnormal_larynx_morphology | 1.84450159 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 1.75553713 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.75289697 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.71757369 |
| 27 | MP0004233_abnormal_muscle_weight | 1.65838257 |
| 28 | MP0004885_abnormal_endolymph | 1.64313126 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.61888749 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.60757040 |
| 31 | MP0001968_abnormal_touch/_nociception | 1.60454757 |
| 32 | MP0008932_abnormal_embryonic_tissue | 1.59573593 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.58816988 |
| 34 | MP0003123_paternal_imprinting | 1.58704121 |
| 35 | MP0000751_myopathy | 1.57975996 |
| 36 | MP0002272_abnormal_nervous_system | 1.57000230 |
| 37 | MP0000955_abnormal_spinal_cord | 1.56799960 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.56403994 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.52906853 |
| 40 | MP0000579_abnormal_nail_morphology | 1.52734784 |
| 41 | MP0001486_abnormal_startle_reflex | 1.49942198 |
| 42 | MP0009840_abnormal_foam_cell | 1.47893569 |
| 43 | MP0005501_abnormal_skin_physiology | 1.47369225 |
| 44 | MP0001970_abnormal_pain_threshold | 1.47312217 |
| 45 | MP0003119_abnormal_digestive_system | 1.46914847 |
| 46 | MP0009672_abnormal_birth_weight | 1.45030345 |
| 47 | MP0001346_abnormal_lacrimal_gland | 1.44870490 |
| 48 | MP0002184_abnormal_innervation | 1.41836198 |
| 49 | MP0008961_abnormal_basal_metabolism | 1.40684491 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.40415315 |
| 51 | MP0000747_muscle_weakness | 1.39207089 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.36266705 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.35684667 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.31495695 |
| 55 | MP0003122_maternal_imprinting | 1.28464975 |
| 56 | MP0002796_impaired_skin_barrier | 1.27928869 |
| 57 | MP0003879_abnormal_hair_cell | 1.25129079 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.24763290 |
| 59 | MP0002269_muscular_atrophy | 1.24573536 |
| 60 | MP0000778_abnormal_nervous_system | 1.24364563 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.23243350 |
| 62 | MP0000467_abnormal_esophagus_morphology | 1.21941198 |
| 63 | MP0008569_lethality_at_weaning | 1.20455175 |
| 64 | MP0009053_abnormal_anal_canal | 1.19407447 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.17168300 |
| 66 | MP0002882_abnormal_neuron_morphology | 1.16496903 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 1.16245991 |
| 68 | MP0003137_abnormal_impulse_conducting | 1.15619995 |
| 69 | MP0004272_abnormal_basement_membrane | 1.15131052 |
| 70 | MP0002152_abnormal_brain_morphology | 1.12165924 |
| 71 | MP0000750_abnormal_muscle_regeneration | 1.11973525 |
| 72 | MP0002089_abnormal_postnatal_growth/wei | 1.11600284 |
| 73 | MP0003315_abnormal_perineum_morphology | 1.10661360 |
| 74 | MP0000534_abnormal_ureter_morphology | 1.09723847 |
| 75 | MP0001188_hyperpigmentation | 1.07409700 |
| 76 | MP0001849_ear_inflammation | 1.07166312 |
| 77 | MP0000566_synostosis | 1.07068697 |
| 78 | MP0000762_abnormal_tongue_morphology | 1.06903641 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.06386848 |
| 80 | MP0000537_abnormal_urethra_morphology | 1.06106713 |
| 81 | MP0002736_abnormal_nociception_after | 1.05425063 |
| 82 | MP0001501_abnormal_sleep_pattern | 1.03346352 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.02415576 |
| 84 | MP0004924_abnormal_behavior | 1.02415576 |
| 85 | MP0002557_abnormal_social/conspecific_i | 1.02059405 |
| 86 | MP0005394_taste/olfaction_phenotype | 1.01209220 |
| 87 | MP0005499_abnormal_olfactory_system | 1.01209220 |
| 88 | MP0003646_muscle_fatigue | 0.99940812 |
| 89 | MP0003861_abnormal_nervous_system | 0.98442011 |
| 90 | MP0000681_abnormal_thyroid_gland | 0.98357783 |
| 91 | MP0000462_abnormal_digestive_system | 0.97232745 |
| 92 | MP0004043_abnormal_pH_regulation | 0.95627497 |
| 93 | MP0003942_abnormal_urinary_system | 0.93923291 |
| 94 | MP0003634_abnormal_glial_cell | 0.92678685 |
| 95 | MP0002234_abnormal_pharynx_morphology | 0.91568018 |
| 96 | MP0001730_embryonic_growth_arrest | 0.90283857 |
| 97 | MP0000604_amyloidosis | 0.90250665 |
| 98 | MP0000350_abnormal_cell_proliferation | 0.90165436 |
| 99 | MP0005330_cardiomyopathy | 0.89226162 |
| 100 | MP0002080_prenatal_lethality | 0.89098252 |
| 101 | MP0003385_abnormal_body_wall | 0.87295397 |
| 102 | MP0004087_abnormal_muscle_fiber | 0.85638412 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.85049330 |
| 104 | MP0004142_abnormal_muscle_tone | 0.84734109 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.83456450 |
| 106 | MP0003186_abnormal_redox_activity | 0.83345508 |
| 107 | MP0004084_abnormal_cardiac_muscle | 0.82985847 |
| 108 | MP0002837_dystrophic_cardiac_calcinosis | 0.82517125 |
| 109 | MP0001905_abnormal_dopamine_level | 0.82221367 |
| 110 | MP0002060_abnormal_skin_morphology | 0.81154276 |
| 111 | MP0000003_abnormal_adipose_tissue | 0.80746525 |
| 112 | MP0002069_abnormal_eating/drinking_beha | 0.80676476 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.79622510 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.79568288 |
| 115 | MP0000049_abnormal_middle_ear | 0.79400031 |
| 116 | MP0002735_abnormal_chemical_nociception | 0.79019131 |
| 117 | MP0000759_abnormal_skeletal_muscle | 0.78499382 |
| 118 | MP0000358_abnormal_cell_content/ | 0.77451220 |
| 119 | MP0004085_abnormal_heartbeat | 0.76763239 |
| 120 | MP0003075_altered_response_to | 0.76615003 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.76215400 |
| 122 | MP0005187_abnormal_penis_morphology | 0.76198701 |
| 123 | MP0008872_abnormal_physiological_respon | 0.75568287 |
| 124 | MP0003077_abnormal_cell_cycle | 0.75372091 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75299675 |
| 126 | MP0002084_abnormal_developmental_patter | 0.74350229 |
| 127 | MP0008789_abnormal_olfactory_epithelium | 0.73834566 |
| 128 | MP0005375_adipose_tissue_phenotype | 0.73746076 |
| 129 | MP0001529_abnormal_vocalization | 0.73520574 |
| 130 | MP0004957_abnormal_blastocyst_morpholog | 0.73374315 |
| 131 | MP0000920_abnormal_myelination | 0.73229516 |
| 132 | MP0009379_abnormal_foot_pigmentation | 0.72752245 |
| 133 | MP0003115_abnormal_respiratory_system | 0.72737010 |
| 134 | MP0008770_decreased_survivor_rate | 0.72437682 |
| 135 | MP0003633_abnormal_nervous_system | 0.71807679 |
| 136 | MP0002085_abnormal_embryonic_tissue | 0.70670842 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.70411759 |
| 138 | MP0008874_decreased_physiological_sensi | 0.69983465 |
| 139 | MP0010771_integument_phenotype | 0.69346747 |
| 140 | MP0004133_heterotaxia | 0.68885303 |
| 141 | MP0003632_abnormal_nervous_system | 0.67299049 |
| 142 | MP0003631_nervous_system_phenotype | 0.66992876 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.66246604 |
| 144 | MP0002752_abnormal_somatic_nervous | 0.65304603 |
| 145 | MP0001299_abnormal_eye_distance/ | 0.64989841 |
| 146 | MP0002229_neurodegeneration | 0.64929646 |
| 147 | MP0000428_abnormal_craniofacial_morphol | 0.63784679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.22816468 |
| 2 | Abnormal gallbladder physiology (HP:0012438) | 4.27585622 |
| 3 | Cholecystitis (HP:0001082) | 4.27585622 |
| 4 | Abnormality of the lower motor neuron (HP:0002366) | 4.10286000 |
| 5 | Visual hallucinations (HP:0002367) | 3.68682499 |
| 6 | Abnormality of glycolysis (HP:0004366) | 3.43219238 |
| 7 | Ventricular fibrillation (HP:0001663) | 3.41401584 |
| 8 | Focal motor seizures (HP:0011153) | 3.33367935 |
| 9 | Focal seizures (HP:0007359) | 3.24609875 |
| 10 | Achilles tendon contracture (HP:0001771) | 3.24552988 |
| 11 | Vertebral compression fractures (HP:0002953) | 3.02413589 |
| 12 | Bundle branch block (HP:0011710) | 2.98756890 |
| 13 | Abnormality of the Achilles tendon (HP:0005109) | 2.97836411 |
| 14 | Ankle clonus (HP:0011448) | 2.88544549 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 2.83563453 |
| 16 | Increased serum pyruvate (HP:0003542) | 2.77626075 |
| 17 | Upper limb amyotrophy (HP:0009129) | 2.69739181 |
| 18 | Distal upper limb amyotrophy (HP:0007149) | 2.69739181 |
| 19 | Difficulty climbing stairs (HP:0003551) | 2.68208222 |
| 20 | Cerebral hypomyelination (HP:0006808) | 2.62039801 |
| 21 | Long palpebral fissure (HP:0000637) | 2.57038096 |
| 22 | Annular pancreas (HP:0001734) | 2.53800315 |
| 23 | Delusions (HP:0000746) | 2.53144701 |
| 24 | Amyotrophic lateral sclerosis (HP:0007354) | 2.52788575 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.48333791 |
| 26 | Hand muscle atrophy (HP:0009130) | 2.43436290 |
| 27 | Insomnia (HP:0100785) | 2.41344852 |
| 28 | Depression (HP:0000716) | 2.39124159 |
| 29 | Action tremor (HP:0002345) | 2.38894580 |
| 30 | Megalencephaly (HP:0001355) | 2.38492594 |
| 31 | Gout (HP:0001997) | 2.37377211 |
| 32 | Ragged-red muscle fibers (HP:0003200) | 2.35016941 |
| 33 | Distal lower limb amyotrophy (HP:0008944) | 2.28900357 |
| 34 | Neuronal loss in central nervous system (HP:0002529) | 2.26467592 |
| 35 | Lower limb amyotrophy (HP:0007210) | 2.26232716 |
| 36 | Stridor (HP:0010307) | 2.24539398 |
| 37 | Impaired social interactions (HP:0000735) | 2.23623009 |
| 38 | Abnormal social behavior (HP:0012433) | 2.23623009 |
| 39 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.22803165 |
| 40 | Broad distal phalanx of finger (HP:0009836) | 2.21968377 |
| 41 | Microvesicular hepatic steatosis (HP:0001414) | 2.20916805 |
| 42 | Cholelithiasis (HP:0001081) | 2.19830685 |
| 43 | Trismus (HP:0000211) | 2.19277976 |
| 44 | Myopathic facies (HP:0002058) | 2.18514581 |
| 45 | Shoulder girdle muscle weakness (HP:0003547) | 2.13965086 |
| 46 | Hyperparathyroidism (HP:0000843) | 2.11977463 |
| 47 | Pointed chin (HP:0000307) | 2.11458675 |
| 48 | Tetraplegia (HP:0002445) | 2.11117919 |
| 49 | Torticollis (HP:0000473) | 2.11038018 |
| 50 | Atrioventricular block (HP:0001678) | 2.10546249 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.09205735 |
| 52 | Atonic seizures (HP:0010819) | 2.07763935 |
| 53 | Rapidly progressive (HP:0003678) | 2.07184611 |
| 54 | Upper limb muscle weakness (HP:0003484) | 2.06512632 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.05814665 |
| 56 | Athetosis (HP:0002305) | 2.05462198 |
| 57 | Epileptic encephalopathy (HP:0200134) | 2.05183956 |
| 58 | Hypercortisolism (HP:0001578) | 2.04409276 |
| 59 | Amblyopia (HP:0000646) | 2.04128562 |
| 60 | Multiple enchondromatosis (HP:0005701) | 2.03510739 |
| 61 | Bronchomalacia (HP:0002780) | 2.03192638 |
| 62 | Mutism (HP:0002300) | 2.02921006 |
| 63 | Ulnar bowing (HP:0003031) | 2.02481731 |
| 64 | Generalized tonic-clonic seizures (HP:0002069) | 2.02301353 |
| 65 | Absence seizures (HP:0002121) | 2.02252847 |
| 66 | Peripheral hypomyelination (HP:0007182) | 2.02136594 |
| 67 | Angiofibromas (HP:0010615) | 2.01841836 |
| 68 | Adenoma sebaceum (HP:0009720) | 2.01841836 |
| 69 | Dialeptic seizures (HP:0011146) | 2.01719382 |
| 70 | Poor eye contact (HP:0000817) | 2.01302212 |
| 71 | Difficulty running (HP:0009046) | 2.00784004 |
| 72 | Ependymoma (HP:0002888) | 2.00212302 |
| 73 | Neoplasm of the heart (HP:0100544) | 1.99613288 |
| 74 | Abnormality of the umbilical cord (HP:0010881) | 1.95776855 |
| 75 | Growth hormone excess (HP:0000845) | 1.95407094 |
| 76 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.93392586 |
| 77 | Hammertoe (HP:0001765) | 1.93252353 |
| 78 | Abnormal eating behavior (HP:0100738) | 1.93047230 |
| 79 | Focal dystonia (HP:0004373) | 1.92442034 |
| 80 | Progressive muscle weakness (HP:0003323) | 1.92378168 |
| 81 | Nuclear cataract (HP:0100018) | 1.92239808 |
| 82 | Termporal pattern (HP:0011008) | 1.92065221 |
| 83 | Insidious onset (HP:0003587) | 1.92065221 |
| 84 | Shallow orbits (HP:0000586) | 1.91399114 |
| 85 | Abnormal atrioventricular conduction (HP:0005150) | 1.91068219 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 1.90765347 |
| 87 | Urinary urgency (HP:0000012) | 1.90630854 |
| 88 | Restlessness (HP:0000711) | 1.90341634 |
| 89 | Obstructive sleep apnea (HP:0002870) | 1.90231227 |
| 90 | Heart block (HP:0012722) | 1.90219788 |
| 91 | Dysdiadochokinesis (HP:0002075) | 1.89971112 |
| 92 | Status epilepticus (HP:0002133) | 1.89833503 |
| 93 | Back pain (HP:0003418) | 1.89529941 |
| 94 | Apathy (HP:0000741) | 1.89506996 |
| 95 | Deep palmar crease (HP:0006191) | 1.89037768 |
| 96 | Spinal rigidity (HP:0003306) | 1.88065114 |
| 97 | Turricephaly (HP:0000262) | 1.86725190 |
| 98 | Sudden death (HP:0001699) | 1.85879511 |
| 99 | Pheochromocytoma (HP:0002666) | 1.84609427 |
| 100 | Genu recurvatum (HP:0002816) | 1.84137397 |
| 101 | Overriding aorta (HP:0002623) | 1.83729949 |
| 102 | Abnormality of the astrocytes (HP:0100707) | 1.83305589 |
| 103 | Astrocytoma (HP:0009592) | 1.83305589 |
| 104 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.82514586 |
| 105 | Cortical dysplasia (HP:0002539) | 1.82227407 |
| 106 | Protrusio acetabuli (HP:0003179) | 1.81252200 |
| 107 | Diminished motivation (HP:0000745) | 1.81015880 |
| 108 | Abnormal neuron morphology (HP:0012757) | 1.80292799 |
| 109 | Abnormality of the motor neurons (HP:0002450) | 1.80292799 |
| 110 | Distal sensory impairment (HP:0002936) | 1.79694905 |
| 111 | Anxiety (HP:0000739) | 1.79455725 |
| 112 | Dysmetria (HP:0001310) | 1.78910180 |
| 113 | Truncus arteriosus (HP:0001660) | 1.78227172 |
| 114 | Hemiparesis (HP:0001269) | 1.77432734 |
| 115 | Global brain atrophy (HP:0002283) | 1.77388908 |
| 116 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.77128845 |
| 117 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.77091304 |
| 118 | Resting tremor (HP:0002322) | 1.76794218 |
| 119 | Hyperthyroidism (HP:0000836) | 1.75333444 |
| 120 | Clonus (HP:0002169) | 1.74449523 |
| 121 | Pelvic girdle muscle weakness (HP:0003749) | 1.74382720 |
| 122 | Ankle contracture (HP:0006466) | 1.74310000 |
| 123 | Abnormality of the gallbladder (HP:0005264) | 1.74013104 |
| 124 | Testicular atrophy (HP:0000029) | 1.73990619 |
| 125 | Craniofacial dystonia (HP:0012179) | 1.73656477 |
| 126 | Progressive cerebellar ataxia (HP:0002073) | 1.73512563 |
| 127 | Hemiplegia (HP:0002301) | 1.72353693 |
| 128 | Hypokinesia (HP:0002375) | 1.72276081 |
| 129 | Short nail (HP:0001799) | 1.71632395 |
| 130 | Heterochromia iridis (HP:0001100) | 1.71624571 |
| 131 | Spastic gait (HP:0002064) | 1.71150970 |
| 132 | Abnormality of dentin (HP:0010299) | 1.70892123 |
| 133 | Premature rupture of membranes (HP:0001788) | 1.70375567 |
| 134 | Reticulocytosis (HP:0001923) | 1.70323201 |
| 135 | Ventricular arrhythmia (HP:0004308) | 1.69667532 |
| 136 | Myotonia (HP:0002486) | 1.69144195 |
| 137 | Impaired pain sensation (HP:0007328) | 1.69114549 |
| 138 | Abnormality of pain sensation (HP:0010832) | 1.69114549 |
| 139 | Muscle fiber splitting (HP:0003555) | 1.68685458 |
| 140 | Rough bone trabeculation (HP:0100670) | 1.66918271 |
| 141 | Selective tooth agenesis (HP:0001592) | 1.66745396 |
| 142 | Fragile skin (HP:0001030) | 1.66498701 |
| 143 | Biconcave vertebral bodies (HP:0004586) | 1.66215947 |
| 144 | Generalized hypotonia (HP:0001290) | 1.65527207 |
| 145 | Fasciculations (HP:0002380) | 1.65279243 |
| 146 | Unilateral renal agenesis (HP:0000122) | 1.65048289 |
| 147 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.64695947 |
| 148 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.64695947 |
| 149 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.64636384 |
| 150 | Hyperacusis (HP:0010780) | 1.64539502 |
| 151 | Foot dorsiflexor weakness (HP:0009027) | 1.64029136 |
| 152 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.63870455 |
| 153 | Microretrognathia (HP:0000308) | 1.63040470 |
| 154 | Muscle stiffness (HP:0003552) | 1.62031369 |
| 155 | Generalized amyotrophy (HP:0003700) | 1.61985949 |
| 156 | Spastic diplegia (HP:0001264) | 1.61043628 |
| 157 | Cervical subluxation (HP:0003308) | 1.60361032 |
| 158 | Hypercalcemia (HP:0003072) | 1.60158378 |
| 159 | Increased connective tissue (HP:0009025) | 1.59871571 |
| 160 | Emotional lability (HP:0000712) | 1.59705221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.98817765 |
| 2 | KSR2 | 2.99808555 |
| 3 | EPHA4 | 2.93337507 |
| 4 | TRIB3 | 2.90124052 |
| 5 | NME2 | 2.75786746 |
| 6 | PAK6 | 2.67575371 |
| 7 | SMG1 | 2.64490505 |
| 8 | LATS2 | 2.62151637 |
| 9 | PRKD3 | 2.51318228 |
| 10 | NEK1 | 2.43849997 |
| 11 | NTRK3 | 2.28607557 |
| 12 | MARK1 | 2.19998234 |
| 13 | NTRK1 | 2.19868982 |
| 14 | TESK2 | 2.16240599 |
| 15 | VRK2 | 2.14581445 |
| 16 | MINK1 | 2.08612647 |
| 17 | ARAF | 2.04513070 |
| 18 | TYRO3 | 1.93759699 |
| 19 | TAOK1 | 1.82539083 |
| 20 | CAMKK1 | 1.80306644 |
| 21 | PRPF4B | 1.76753545 |
| 22 | KSR1 | 1.76245776 |
| 23 | SIK1 | 1.64877605 |
| 24 | BUB1 | 1.62426593 |
| 25 | DAPK2 | 1.60678260 |
| 26 | PIM2 | 1.57387293 |
| 27 | PBK | 1.48768713 |
| 28 | STK38 | 1.42597361 |
| 29 | IRAK3 | 1.35921008 |
| 30 | EPHA2 | 1.33114933 |
| 31 | SCYL2 | 1.32407452 |
| 32 | GRK5 | 1.30661064 |
| 33 | LIMK1 | 1.28494849 |
| 34 | PHKG2 | 1.26438938 |
| 35 | PHKG1 | 1.26438938 |
| 36 | ALK | 1.21915101 |
| 37 | LMTK2 | 1.21636842 |
| 38 | NTRK2 | 1.21213537 |
| 39 | PAK3 | 1.19261750 |
| 40 | MAP3K4 | 1.18419475 |
| 41 | SIK3 | 1.16902833 |
| 42 | PKN2 | 1.16395531 |
| 43 | CDK14 | 1.15379094 |
| 44 | UHMK1 | 1.12448540 |
| 45 | DDR2 | 1.11165405 |
| 46 | CDK15 | 1.09916120 |
| 47 | CDK18 | 1.05923868 |
| 48 | ICK | 1.05619882 |
| 49 | CDK5 | 1.03582209 |
| 50 | MAP2K4 | 1.02775537 |
| 51 | TESK1 | 1.02516397 |
| 52 | RAF1 | 1.01996234 |
| 53 | CDK11A | 1.00559371 |
| 54 | PDGFRA | 0.99791579 |
| 55 | MAP3K2 | 0.99387804 |
| 56 | DAPK3 | 0.91765823 |
| 57 | CAMKK2 | 0.90340905 |
| 58 | CDK12 | 0.88033107 |
| 59 | RIPK1 | 0.87019702 |
| 60 | DAPK1 | 0.85792319 |
| 61 | PNCK | 0.84490614 |
| 62 | PTK2 | 0.83682823 |
| 63 | BRAF | 0.83468843 |
| 64 | PRKCG | 0.83249934 |
| 65 | CDK19 | 0.82735125 |
| 66 | CSNK1G3 | 0.81212618 |
| 67 | PINK1 | 0.80546595 |
| 68 | LRRK2 | 0.80410421 |
| 69 | BRSK1 | 0.79441422 |
| 70 | MAP2K1 | 0.79284543 |
| 71 | FER | 0.78030537 |
| 72 | EPHB1 | 0.77765272 |
| 73 | EIF2AK1 | 0.76630419 |
| 74 | CDK7 | 0.74874835 |
| 75 | ABL2 | 0.74741617 |
| 76 | MOS | 0.72207710 |
| 77 | CSNK1A1L | 0.71035528 |
| 78 | PRKD2 | 0.69148558 |
| 79 | RET | 0.68960496 |
| 80 | ERN1 | 0.68893433 |
| 81 | MAP3K11 | 0.68590450 |
| 82 | MAP3K3 | 0.65715452 |
| 83 | PDK2 | 0.65707020 |
| 84 | DMPK | 0.65556856 |
| 85 | SIK2 | 0.65396499 |
| 86 | PAK1 | 0.64655813 |
| 87 | BMX | 0.64453591 |
| 88 | STK11 | 0.64003714 |
| 89 | MST1R | 0.62814837 |
| 90 | SRPK1 | 0.61662788 |
| 91 | MARK2 | 0.61645455 |
| 92 | AURKA | 0.61052617 |
| 93 | DYRK1B | 0.60667153 |
| 94 | PRKCI | 0.58543704 |
| 95 | ERBB4 | 0.58155399 |
| 96 | FGFR4 | 0.57306347 |
| 97 | RPS6KA2 | 0.55678806 |
| 98 | MAP2K2 | 0.55382346 |
| 99 | PTK6 | 0.54681860 |
| 100 | NME1 | 0.54664939 |
| 101 | KDR | 0.54617054 |
| 102 | PDPK1 | 0.54303619 |
| 103 | PAK4 | 0.54184580 |
| 104 | CSNK1E | 0.53972060 |
| 105 | PDK4 | 0.53936068 |
| 106 | PDK3 | 0.53936068 |
| 107 | MAP3K1 | 0.52843170 |
| 108 | ILK | 0.52476037 |
| 109 | PRKG2 | 0.52145258 |
| 110 | ROCK2 | 0.51046973 |
| 111 | BCKDK | 0.50835609 |
| 112 | TTN | 0.50473753 |
| 113 | AKT3 | 0.50404218 |
| 114 | PRKCZ | 0.46308498 |
| 115 | AKT2 | 0.45652680 |
| 116 | CAMK1 | 0.45558741 |
| 117 | MAP3K8 | 0.44758622 |
| 118 | MAPKAPK3 | 0.44672911 |
| 119 | EPHB2 | 0.42996075 |
| 120 | MAP2K7 | 0.42962740 |
| 121 | TTK | 0.42854992 |
| 122 | NEK2 | 0.42404831 |
| 123 | MET | 0.42369224 |
| 124 | CAMK2G | 0.42083784 |
| 125 | MTOR | 0.40573817 |
| 126 | CDK9 | 0.39487091 |
| 127 | EEF2K | 0.38639990 |
| 128 | MAP3K12 | 0.37793606 |
| 129 | MAPK10 | 0.37572714 |
| 130 | PAK2 | 0.37498434 |
| 131 | IRAK2 | 0.37070586 |
| 132 | CAMK2B | 0.36367949 |
| 133 | CDC42BPA | 0.35845608 |
| 134 | TAOK2 | 0.34907521 |
| 135 | CAMK2A | 0.34846203 |
| 136 | CSNK1G2 | 0.34626402 |
| 137 | PDK1 | 0.32877622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.03723243 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.97832552 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.49672796 |
| 4 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.38532552 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.07148635 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.97607311 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.93155105 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.93013637 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.85656196 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.84086524 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 1.79538848 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.76060073 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.72497632 |
| 14 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70056294 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.68881412 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.66951784 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.66857444 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.65064689 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.64971979 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.56957424 |
| 21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.54302354 |
| 22 | Gap junction_Homo sapiens_hsa04540 | 1.52870403 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.52827906 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.52292980 |
| 25 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.51726925 |
| 26 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.45069236 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.44323490 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44224624 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44056601 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43413496 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.42613355 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42198110 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40490660 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.37262888 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.35657305 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35639124 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.33343962 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.29706113 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.27933530 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.27492538 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 1.27291203 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23782130 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23564006 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.21877383 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.19582169 |
| 46 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.18732345 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17296131 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16958626 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15808235 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15068728 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 1.10256496 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06630389 |
| 53 | Bladder cancer_Homo sapiens_hsa05219 | 1.03846720 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03494759 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02887440 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01076904 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99108034 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.98463938 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96111216 |
| 60 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.95067055 |
| 61 | Tight junction_Homo sapiens_hsa04530 | 0.95031138 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94556053 |
| 63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93792121 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93070925 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92794599 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.89722711 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87971569 |
| 68 | Spliceosome_Homo sapiens_hsa03040 | 0.87620044 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.87582085 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86267281 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85870696 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84971326 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83076984 |
| 74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82402127 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.81639933 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81373641 |
| 77 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80823339 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.79810147 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79711743 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.79371498 |
| 81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.79351223 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.78665731 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78519747 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78471487 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.77323612 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76313638 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75067086 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74398721 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74286078 |
| 90 | Taste transduction_Homo sapiens_hsa04742 | 0.74070153 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73107103 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72868493 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.72019366 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71524937 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71159113 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69904381 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69894165 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69791168 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69484571 |
| 100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68955486 |
| 101 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68259275 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67801622 |
| 103 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67696975 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67405584 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67196615 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67159402 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66013733 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65190066 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64857507 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63735740 |
| 111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63369027 |
| 112 | Parkinsons disease_Homo sapiens_hsa05012 | 0.63208158 |
| 113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62173130 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61975611 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60901953 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60582169 |
| 117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60158197 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59719940 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59570980 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58475696 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57989875 |
| 122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57612408 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57350982 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56812147 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55789919 |
| 126 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53109424 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51876645 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50884839 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50544487 |
| 130 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.49853910 |
| 131 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.49327579 |
| 132 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48681476 |
| 133 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47522794 |
| 134 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47064130 |
| 135 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46833627 |
| 136 | Salmonella infection_Homo sapiens_hsa05132 | 0.46351283 |
| 137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46150246 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45809951 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42956174 |
| 140 | Cell cycle_Homo sapiens_hsa04110 | 0.38250903 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37075426 |
| 142 | Lysosome_Homo sapiens_hsa04142 | 0.34254638 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32610594 |
| 144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32471445 |
| 145 | Mismatch repair_Homo sapiens_hsa03430 | 0.32133102 |
| 146 | Adherens junction_Homo sapiens_hsa04520 | 0.28867025 |

